Involvement of the M2 muscarinic receptor in contractions of the guinea pig trachea, guinea pig esophagus, and rat fundus

Biochemical Pharmacology

Volumn 51, Issue 6, 1996, Pages 779-788

  Thomas, Elizabeth A ^a,b   Ehlert, Frederick J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

esophagus, M2 muscarinic receptors and contraction; fundus, M2 muscarinic receptors and contraction; muscarinic receptors, M2 and M3 subtypes; muscle, smooth, contraction of trachea, M2 muscarinic receptors; pertussis toxin, inhibition of tracheal smooth muscle contractions; trachea, M2 muscarinic receptors and contraction

Indexed keywords

1 (2 CHLOROETHYL) 4 DIPHENYLACETOXYPIPERIDINE; FORSKOLIN; HISTAMINE; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR; OTENZEPAD; OXOTREMORINE M; PARA FLUOROHEXAHYDROSILADIFENIDOL; PERTUSSIS TOXIN; RECEPTOR SUBTYPE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BORDETELLA VIRULENCE FACTOR; CYCLIC AMP; DRUG DERIVATIVE; ISOPRENALINE; MUSCARINIC RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; OXOTREMORINE; PIRENZEPINE; SEROTONIN;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ANTAGONISM; ESOPHAGUS; GUINEA PIG; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE CONTRACTION; STOMACH MUSCLE; TRACHEA MUSCLE; ANIMAL; CLASSIFICATION; COMPARATIVE STUDY; DRUG EFFECT; IN VITRO STUDY; METABOLISM; MUSCLE CONTRACTION; PHYSIOLOGY; SMOOTH MUSCLE; SPRAGUE DAWLEY RAT; STOMACH FUNDUS; TRACHEA; ULTRASTRUCTURE;

ADRENERGIC BETA-AGONISTS; ANIMALS; CYCLIC AMP; ESOPHAGUS; FORSKOLIN; GASTRIC FUNDUS; GUINEA PIGS; HISTAMINE; ISOPROTERENOL; MALE; MUSCARINIC ANTAGONISTS; MUSCLE CONTRACTION; MUSCLE, SMOOTH; OXOTREMORINE; PERTUSSIS TOXIN; PIRENZEPINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, MUSCARINIC; SEROTONIN; TRACHEA; VIRULENCE FACTORS, BORDETELLA;

EID: 0029669958     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-2952(95)02396-8     Document Type: Article

References (51)

1. Roffel AF, Meurs H, Elzinga CRS and Zaagsma J, Characterization of the muscarinic receptor subtypes involved in phosphoinositide metabolism in bovine tracheal smooth muscle. Br J Pharmacol 99: 293-296, 1990.
2. Candell LM, Yun SH, Tran LLP and Ehlert FJ, Differential coupling of subtypes of the muscarinic receptor to adenylate cyclase and phosphoinositide hydrolysis in the longitudinal muscle of the rat ileum. Mol Pharmacol 38: 689-697, 1990.
3. 2 muscarinic receptors in longitudinal ileal smooth muscle membranes. Eur J Pharmacol 45: 305-311, 1988.
4. Yang CM, Characterization of muscarinic receptors in dog tracheal smooth muscle cells. J Auton Pharmacol 11: 51-61, 1991.
5. 2 muscarinic receptor in smooth muscle of guinea pig ileum. Mol Pharmacol 44: 102-110, 1993.
6. 3-mediated contractions and phosphoinositide hydrolysis. J Pharmacol Exp Ther 271: 1042-1050, 1994.
7. 2 muscarinic receptors in the guinea pig ileum. Life Sci 56: 965-971, 1995.
8. 2 receptors and β-adrenoceptor subtypes in guinea-pig isolated ileum. Br J Pharmacol 114: 49-56, 1995.
9. Lambrecht G, Feifel R, Moser U, Wagner-Roder M, Choo LK, Camus J, Tastenoy M, Waelbroek M, Strohmann C, Tacke R, Rodrigues de Miranda JF, Christophe J and Mustchler E, Pharmacology of hexahydro-difenidol, hexahydro-sila-difenidol, and related selective muscarinic antagonists. Trends Pharmacol Sci (Suppl) 10: 60-64, 1989.
10. Noronha-blob L, Lowe V, Patton A, Canning B, Costello D and Kinnier WJ, Muscarinic receptors: Relationships among phosphoinositide breakdown, adenylate cyclase inhibition, in vitro detrusor muscle contractions and in vivo cystometrogram studies in guinea pig bladder. J Pharmacol Exp Ther 249: 843-851, 1989.
11. 3 subtypes. Mol Pharmacol 40: 943-951, 1991.
12. Yang CM, Chou S and Sung T, Muscarinic receptor subtypes coupled to generation of different second messengers in isolated tracheal smooth muscle cells. Br J Pharmacol 104: 613-618, 1991.
13. Del Tacca M, Danes R, Blandizzi C and Bernardini MC, Differential affinities of AF-DX 116, atropine and pirenzepine for muscarinic receptors in guinea pig gastric fundus, atria and urinary bladder: Might atropine distinguish among muscarinic receptor subtypes? Pharmacology 40: 241-249, 1990.
14. Li Z, Ruan Y, Guo ZD, Cong H, Zhang KY and Takemura H, Functional and localization of high and low affinity binding sites to muscarinic receptors in longitudinal and circular smooth muscles of human stomach. Res Commun Chem Pathol Pharmacol 67: 31-42, 1990.
15. Eglen RM and Whiting RL, Comparison of the muscarinic receptors of the guinea-pig oesophageal muscularis mucosae and trachea in vitro. J Auton Pharmacol 8: 181-189, 1988.
16. Maeda A, Kubo T, Mishina M and Numa S, Tissue distribution of mRNAs encoding muscarinic acetylcholine receptor subtypes. FEBS Lett 239: 339-342, 1988.
17. Fryer AD and El-Fakahany EE, Identification of three muscarinic receptor subtypes in rat lung using binding studies with selective antagonists. Life Sci 47: 611-618, 1990.
18. Madison JM, Jones CA, Tom-Moy M and Brown JK, Affinities of pirenzepine for muscarinic cholinergic receptors in membranes isolated from bovine tracheal mucosa and smooth muscle. Am Rev Respir Dis 135: 719-724, 1987.
19. 2 selective antagonist AF-DX 116 shows high affinity for muscarinic receptors in bovine tracheal membranes. Naunyn Schmiedebergs Arch Pharmacol 335: 593-595, 1987.
20. 4-induced contraction in the guinea-pig trachea. Eur J Pharmacol 102: 549-553, 1984.
21. Russell JA, Differential inhibitory effect of isoproterenol on contractions of canine airways. J Appl Physiol 57: 801-807, 1984.
22. Koenig SM, Mitchell RW, Kelly E, White SR, Leff AR and Popovich KJ, β-Adrenergic relaxation of dog trachealis: Contractile agonist-specific interaction. J Appl Physiol 67: 181-185, 1989.
23. Gunst SJ, Stropp JQ and Flavahan NA, Muscarinic receptor reserve and β-adrenergic sensitivity in tracheal smooth muscle. J Appl Physiol 67: 1294-1298, 1989.
24. 2 receptors in functional antagonism in bovine trachea. Br J Pharmacol 115: 665-671, 1995.
25. 2 muscarinic receptors inhibit isoproterenol-induced relaxation of canine airway smooth muscle. J Pharmacol Exp Ther 262: 119-126, 1992.
26. 3 receptor stimulation and antagonism on responses to isoprenaline of guinea-pig trachea in vitro. Br J Pharmacol 112: 179-187, 1994.
27. 3 receptors in guinea-pig trachea: Effects of receptor alkylation. Eur J Pharmacol 278: 195-201, 1995.
28. Emmerson J and Mackay D, The zig-zag tracheal strip. J Pharm Pharmacol 31: 798, 1979.
29. Coleman RA, Methods in prostanoid receptors classification. In: Prostaglandins and Related Substances (Eds. Benedetto E, McDonald-Gibson RG, Nigam S and Slater TF), pp. 267-301. IRL Press, Oxford, 1987.
30. Kamikawa Y, Uchida K and Shimo Y, Heterogeneity of muscarinic receptors in the guinea pig esophageal muscularis mucosae and ileal longitudinal muscle. Gastroenterology 88: 706-716, 1985.
31. Watts SW and Cohen ML, Time-dependent improvement in guinea pig tracheal contractility: Modification by cyclooxygenase inhibitors. J Pharmacol Exp Ther 266: 950-957, 1993.
32. Muccitelli R, Tucker SS, Hay DWP, Torphy TJ and Wasserman MA, Is the guinea pig isolated trachea a good in vitro model of human large and central airways? Comparison of leukotriene-, methacholine-, histamine-and antigen-induced contractions. J Pharmacol Exp Ther 243: 467-473, 1987.
33. Undem BJ and Adams GK, An analysis of the functional interactions of selected contractile agonists in the guinea pig isolated trachea. J Pharmacol Exp Ther 246: 47-53, 1988.
34. Small RC, Good DM, Dixon JS and Kennedy I, The effects of epithelium removal on the actions of cholinomimetic drugs in opened segments and perfused tubular preparations of guinea pig trachea. Br J Pharmacol 100: 516-522, 1990.
35. Mansour S and Daniel EE, Maintenance of tone, role of arachidonate metabolites, and effects of sensitization in guinea pig trachea. Can J Physiol Pharmacol 64: 1096-1103, 1986.
36. Paton WDM, A theory of drug action based on the rate of drug receptor combination. Proc R Soc Lond B Biol Sci 154: 21-69, 1961.
37. Thomas EA, Hsu HH, Griffin MT, Hunter AL, Luong T and Ehlert FJ, Conversion of N-(2-chloroethyl)-4-piperidinyl diphenylacetate (4-DAMP mustard) to an aziridinium ion and its interaction with muscarinic receptors in various tissues. Mol Pharmacol 41: 718-726, 1992.
38. Monferini E, Giraldo E and Ladinsky H, Characterization of the muscarinic receptor in the rat urinary bladder. Eur J Pharmacol 147: 453-458, 1988.
39. Lambrecht G, Feifel R, Wagner-Roser M, Strohmann C, Zilch H, Tacke R, Waelbroeck M, Christophe J, Boddecke H and Mutschler E, Affinity profiles of hexahydro-sila-difenidol analogues at muscarinic receptor subtypes. Eur J Pharmacol 168: 71-78, 1989.
40. Pedder KE, Eveleigh P, Pouner D, Hulme E and Birdsall NJM, Modulation of the structure-binding relationships of antagonists for muscarinic acetylcholine receptor subtypes. Br J Pharmacol 103: 1561-1567, 1991.
41. Kashihara K, Varga EV, Waite SL, Roeske WR and Yamamura HI, Cloning of the rat M3, M4 and M5 muscarinic acetylcholine receptor genes by the polymerase chain reaction (PCR) and the pharmacological characterization of the expressed genes. Life Sci 51: 955-971, 1992.
42. Eglen RM, Harris GC, Cox H, Sullivan AO, Stefanich E and Whiting RL, Characterization of the interaction of the cervane alkaloid, imperialine, at muscarinic receptors in vitro. Naunyn Schmiedebergs Arch Pharmacol 346: 144-151, 1992.
43. Ringdahl B, Structural requirements for muscarinic receptor occupation and receptor activation by oxotremorine analogs in the guinea-pig ileum. J Pharmacol Exp Ther 232: 67-73, 1985.
44. Katada T and Ui M, Direct modification of the membrane adenylate cyclase system by islet activating protein due to ADP-ribosylation of a membrane protein. J Biol Chem 257: 7210-7216, 1982.
45. Eglen RM, Huff MM, Montgomery WW and Whiting RL, Differential effects of pertussis toxin and lithium on muscarinic responses in the atria and ileum: Evidence for receptor heterogeneity. Br J Pharmacol 91: 6-8, 1987.
46. Kurose H, Katada T, Amano T and Ui M, Specific uncoupling by islet-activating protein, pertussis toxin, of negative signal transduction via α-adrenergic, cholinergic, and opiate receptors in neuroblastoma × glioma hybrid cells. J Biol Chem 258: 4870-4875, 1983.
47. 2β-selective muscarinic antagonist. Eur J Pharmacol 152: 193-194, 1988.
48. Eglen RM, Michel AD, Montgomery WW, Kunysz EA, Machado CA and Whiting RL, The interaction of parafluorohexahydrosiladiphenidol at muscarinic receptors in vitro. Br J Pharmacol 99: 637-642, 1990.
49. Eglen RM, Cornett CM and Whiting RL, Interaction of p-F-HHSiD (p-fluro-hexahydrosila-difenidol) at muscarinic receptors in guinea-pig trachea. Naunyn Schmiedebergs Arch Pharmacol 342: 394-399, 1990.
50. Jones CA, Madison JM, Tom-Moy M and Brown JK, Muscarinic cholinergic inhibition of adenylate cyclase in airway smooth muscle. Am J Physiol 253: C97-C104, 1987.
51. Sankary RM, Jones CA, Madison JM and Brown JK, Muscarinic cholinergic inhibition of cyclic AMP accumulation in airway smooth muscle: Role of a pertussis toxin-sensitive protein. Am Rev Respir Dis 138: 145-150, 1987.